Do behavioral pharmacology findings predict clinical trial outcomes? A proof-of-concept in medication development for alcohol use disorder
Lara A. Ray(University of California, Los Angeles), Spencer Bujarski(University of California, Los Angeles), Han Du(University of California, Los Angeles), Daniel Roche(University of Maryland, Baltimore), ReJoyce Green(Medical University of South Carolina)
Cited by 24
Related Papers
State-of-the-art behavioral and pharmacological treatments for alcohol use disorder
|The American Journal of Drug and Alcohol Abuse|2018|137
Effects of varenicline on subjective craving and relative reinforcing value of cigarettes
|Drug and Alcohol Dependence|2018|64
Naltrexone effects on subjective responses to alcohol in the human laboratory: A systematic review and meta‐analysis
|Addiction Biology|2019|60
Predictors of Substance Use Initiation by Early Adolescence
|American Journal of Psychiatry|2024|60
Efficacy of Combining Varenicline and Naltrexone for Smoking Cessation and Drinking Reduction: A Randomized Clinical Trial
|American Journal of Psychiatry|2021|37